Logo-jre
Submitted: 20 Sep 2024
Accepted: 05 Nov 2024
ePublished: 30 Nov 2024
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Ren Endocrinol. 2024;10: e25175.
doi: 10.34172/jre.2024.25175
  Abstract View: 30
  PDF Download: 36

Mini-Review

Effects of ACE inhibitors/ARBs on lung cancer; an updated mini-review on recent data

Zahra Golestani Hotkani 1 ORCID logo, Tella Sadighpour 2 ORCID logo, Ali Shirbacheh 3 ORCID logo, Kamran Shirbache 4* ORCID logo

1 Department of Bioscience, University of Milan, Milan, Italy.
2 Resident Physician at NH Dartmouth Family Medicine Residency (NHDFMR), Concord Hospital, New Hampshire, USA.
3 Urgences, Centre Hospitalier de l’Agglomération de Nevers, Nevers, France.
4 Hôpital Robert Debré, Groupe Hospitalier Universitaire AP-HP Nord-Université Paris-Cité, France.
*Corresponding Author: Kamran Shirbache, Email: Kamranshirbache@gmail.com

Abstract

Several observational studies have indicated a potential protective effect of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) against lung cancer. These investigations have demonstrated a reduced risk of lung cancer among individuals utilizing ACEIs or ARBs compared to those not receiving these medications. However, it is crucial to acknowledge that observational studies cannot establish a cause-and-effect relationship, as other confounding factors may be at play. Conversely, conflicting outcomes have been reported in certain studies, revealing no discernible association between ACEIs/ARBs and the risk of lung cancer. Furthermore, limited evidence from randomized controlled trials specifically designed to investigate this relationship exists. It is imperative to recognize that these trials have inherent limitations, including potential biases and confounding factors. Therefore, additional research is essential to ascertain a definitive connection between ACEIs/ARBs and lung cancer. This review seeks to assess the available data and explore potential mechanisms underlying this association.

Citation: Golestani Hotkani Z, Sadighpour T, Shirbacheh A, Shirbache K. Effects of ACE inhibitors/ARBs on lung cancer; an updated mini-review on recent data. J Ren Endocrinol. 2024;10:e25175. doi: 10.34172/jre.2024.25175.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 29

Your browser does not support the canvas element.


PDF Download: 36

Your browser does not support the canvas element.